Clearmind Medicine Inc (CMND)

02:25 AM

Clearmind Medicine Inc. Stock Analysis and ForecastRapidly expanding wealth - PrintWeekIndia

02:25 AM

Jul 24, 2025

Is Clearmind Medicine Inc. a good long term investmentHigh-performance investment picks - PrintWeekIndia

Jul 24, 2025

Jul 24, 2025

Why TRUMP(maga) Will ExplodeMarket Ready Callouts - Newser

Jul 24, 2025

Jul 23, 2025

What drives Clearmind Medicine Inc. stock priceExceptional trading results - Autocar Professional

Jul 23, 2025

Jul 23, 2025

What analysts say about Clearmind Medicine Inc. stockPowerful growth strategies - Autocar Professional

Jul 23, 2025

Jul 23, 2025

Clearmind Medicine Inc Completes Initiation of Leading Israeli Clinical Site for Phase I/IIa Trial of CMND-100 in Alcohol Use Disorder - MarketScreener

Jul 23, 2025

Jul 23, 2025

Clearmind Medicine Completes Initiation of Leading Israeli Clinical Site for Phase I/IIa Trial of CMND-100 in Alcohol Use Disorder - The Manila Times

Jul 23, 2025

Jul 23, 2025

Clearmind advances AUD treatment with new trial site in Tel Aviv - Investing.com

Jul 23, 2025

Jul 23, 2025

Clearmind Medicine Inc. Announces Successful Site Initiation for Phase I/IIa Trial of CMND-100 for Alcohol Use Disorder at Tel Aviv Sourasky Medical Center - Nasdaq

Jul 23, 2025

Jul 21, 2025

Clearmind Medicine Surges 18.99%: What's Fueling This Volatile Biotech Rally? - AInvest

Jul 21, 2025

Jul 20, 2025

How Clearmind Medicine Inc. stock reacts to Fed policy changesFree Access to Community with 300% Return - beatles.ru

Jul 20, 2025

Jul 16, 2025

What makes Clearmind Medicine Inc. stock price move sharplySmart Money Trade Setups - beatles.ru

Jul 16, 2025

Jul 16, 2025

Clearmind Expands its Clinical Trial for Alcohol Use, New Site Activated and Additional Participant Enrolled - MarketScreener

Jul 16, 2025

Jul 15, 2025

How Clearmind Medicine Inc. stock performs during market volatilityFree High-Accuracy Stock Picks - Newser

Jul 15, 2025

Jul 15, 2025

Why Clearmind Medicine Inc. stock attracts strong analyst attentionTriple Return With Stability - Newser

Jul 15, 2025

Jul 15, 2025

Clearmind Expands Its Clinical Trial for Alcohol Use: New Site Activated and Additional Participant Enrolled - MarketScreener

Jul 15, 2025

Jul 15, 2025

Clearmind expands phase I/IIa trial for alcohol use disorder treatment By Investing.com - Investing.com South Africa

Jul 15, 2025

Jul 15, 2025

Clearmind expands phase I/IIa trial for alcohol use disorder treatment - Investing.com India

Jul 15, 2025

Jul 15, 2025

Clearmind Medicine Inc. Expands Phase I/IIa Clinical Trial for CMND-100 to Johns Hopkins University to Address Alcohol Use Disorder - Nasdaq

Jul 15, 2025

Jul 15, 2025

Clearmind Expands its Clinical Trial for Alcohol Use: New Site Activated and Additional Participant Enrolled - The Manila Times

Jul 15, 2025

Jul 09, 2025

Clearmind Medicine (NASDAQ:CMND) Stock Price Up 4.5% – Here’s Why - Defense World

Jul 09, 2025

Jul 09, 2025

Alcohol Use Disorder Market Report 2025-2035 Featuring Clearmind Medicine, Purdue Pharma, Psyence Biomedical, Eli Lilly and Co, Tempero Bio,, Nxera Pharma, Novo Nordisk, Adial, Alkermes, Lundbeck - Yahoo Finance

Jul 09, 2025

Jul 04, 2025

Clearmind Medicine Soars 32.89% on Clinical Trial Approval - AInvest

Jul 04, 2025

Jul 03, 2025

CMND’s Stock Market Odyssey: A Year of Growth, Decline, and Resilience - investchronicle.com

Jul 03, 2025

Jul 03, 2025

Clearmind Gains IRB Approval At TASMC For Alcohol Use Disorder Drug Trial - Nasdaq

Jul 03, 2025